Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT02086552 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
DRUG: Sonidegib

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]